![]() Epidemiology
Focus on Advanced Metastatic Disease
Incidence of Metastatic Prostate Cancer
Prostate cancer is expected to account for an estimated 33% (230,110) of incident cases and 10% of deaths from cancer in men in 2004.1 Prostate cancer is generally slow-growing, but as the disease progresses, it metastasizes, primarily to bone (stage D).
After lung cancer, prostate cancer is the leading cause of cancer-related deaths among men in the United States.1 The incidence of prostate cancer increases with age and is found most often in men older than age 50; more than 70% of all prostate tumors are found in men older than 65. It is more common in African American men, in whom it is more aggressive and progressive and results in more advanced disease. These men also have a higher grade carcinoma at diagnosis. Although prostate cancer is less common in Asian and American Indian men, the risk for prostate cancer appears to increase in Asian men the longer they live in Western culture. Prostate cancer is less common in Asia and in Central America; a diet lower in dietary fats and red meat, along with more exposure to sunlight and therefore higher levels of vitamin D, may partially account for these differences.2 Causes and Risk Factors
The cause of prostate cancer is still unclear; however, certain correlations seem to have developed.3
In advanced disease, metastases to the bones of the pelvis, spine, and ribs are especially common. These metastases make the bone more susceptible to complications, such as fractures, and are usually painful. Treatment-Related Osteoporosis
Osteoporosis is common in men as well as women, and in the United States, it is prevalent in more than 1.5 million men older than 65, and another 3.5 million men are at risk.4 In men with advanced metastatic prostate cancer, androgen deprivation treatment to arrest the spread of cancer may contribute to additional bone loss as a result of increased bone turnover and a decrease in bone mineral density. These effects can result in skeletal-related events such as fractures,4 spinal cord compression, and pain. This condition is referred to as treatment-related osteoporosis or cancer-treatmentinduced bone loss.
Mortality and Survival
Prostate cancer can be treated effectively by surgery or radiation if it is diagnosed at an early stage. However, many men require additional treatment due to recurrence of the cancer. While in some men the disease is very aggressive and requires treatment, in others it is slow-growing and unlikely to cause serious problems.
The 5-year survival rate for prostate cancer diagnosed at all stages is 98%. The relative 10-year survival rate is 84%, and the 15-year survival rate is 56%.5 References
|